GC0000094A - New pseudopolymorphic forms of 2-Ä2-Ä4-bis(4-fluorophenyl)methylÜ-1-piperazinylÜethoxyÜ acetic acid dihydrochloride. - Google Patents

New pseudopolymorphic forms of 2-Ä2-Ä4-bis(4-fluorophenyl)methylÜ-1-piperazinylÜethoxyÜ acetic acid dihydrochloride.

Info

Publication number
GC0000094A
GC0000094A GCP199836A GC0000094A GC 0000094 A GC0000094 A GC 0000094A GC P199836 A GCP199836 A GC P199836A GC 0000094 A GC0000094 A GC 0000094A
Authority
GC
Cooperation Council for the Arab states of the Gulf
Prior art keywords
piperazinylüethoxyü
methylü
fluorophenyl
bis
acetic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Monique Berwaer
Guy Bodson
Michel Deleers
Charles Dogimont
Domenico Fanara
Jacques Timmermans
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Application granted granted Critical
Publication of GC0000094A publication Critical patent/GC0000094A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
GCP199836 1997-11-26 1998-11-25 New pseudopolymorphic forms of 2-Ä2-Ä4-bis(4-fluorophenyl)methylÜ-1-piperazinylÜethoxyÜ acetic acid dihydrochloride. GC0000094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride

Publications (1)

Publication Number Publication Date
GC0000094A true GC0000094A (en) 2005-06-29

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
GCP199836 GC0000094A (en) 1997-11-26 1998-11-25 New pseudopolymorphic forms of 2-Ä2-Ä4-bis(4-fluorophenyl)methylÜ-1-piperazinylÜethoxyÜ acetic acid dihydrochloride.

Country Status (39)

Country Link
US (2) US6262057B1 (cs)
EP (2) EP0919550A1 (cs)
JP (2) JP3996348B2 (cs)
KR (1) KR100557711B1 (cs)
CN (1) CN100406448C (cs)
AR (1) AR017676A1 (cs)
AT (1) ATE203237T1 (cs)
AU (1) AU735819B2 (cs)
BG (1) BG64155B1 (cs)
BR (1) BR9815405A (cs)
CA (1) CA2310318C (cs)
CO (1) CO4980892A1 (cs)
CZ (1) CZ295972B6 (cs)
DE (1) DE69801163T2 (cs)
DK (1) DK1034171T3 (cs)
EG (1) EG23776A (cs)
ES (1) ES2161552T3 (cs)
GC (1) GC0000094A (cs)
GR (1) GR3036702T3 (cs)
HU (1) HUP0100343A3 (cs)
ID (1) ID24964A (cs)
IL (1) IL135544A (cs)
MA (1) MA26569A1 (cs)
MY (1) MY119653A (cs)
NO (1) NO314692B1 (cs)
NZ (1) NZ504461A (cs)
PE (1) PE134899A1 (cs)
PL (1) PL190871B1 (cs)
PT (1) PT1034171E (cs)
RS (1) RS49904B (cs)
RU (1) RU2182575C2 (cs)
SI (1) SI20325A (cs)
SK (1) SK283237B6 (cs)
TN (1) TNSN98214A1 (cs)
TR (1) TR200001505T2 (cs)
TW (1) TWI225053B (cs)
UA (1) UA54568C2 (cs)
WO (1) WO1999028310A1 (cs)
ZA (1) ZA9810780B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047689A2 (en) * 2000-12-15 2002-06-20 Ucb, S.A. Use of cetirizine or efletirizine for preventing urticaria
EP1414460A1 (en) * 2001-07-26 2004-05-06 Ucb, S.A. Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
EP2266533A3 (en) * 2002-06-25 2011-12-14 Acrux DDS Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
JP2007500197A (ja) * 2003-05-28 2007-01-11 ユセベ ファルシム ソシエテ アノニム 持続性アレルギー性鼻炎の治療のためのエフレチリジンの使用
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
JPS57149282A (en) * 1981-02-06 1982-09-14 Ucb Sa 2-(4-(diphenylmethyl)-1-piperazinyl)acetic acid and their derivatives as medicine
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.

Also Published As

Publication number Publication date
CO4980892A1 (es) 2000-11-27
BG64155B1 (bg) 2004-02-27
RS49904B (sr) 2008-08-07
YU31600A (sh) 2002-03-18
JP2001524548A (ja) 2001-12-04
EP1034171B1 (en) 2001-07-18
DE69801163D1 (en) 2001-08-23
CZ295972B6 (cs) 2005-12-14
IL135544A (en) 2004-02-08
HUP0100343A2 (hu) 2001-07-30
ES2161552T3 (es) 2001-12-01
KR100557711B1 (ko) 2006-03-07
JP3996348B2 (ja) 2007-10-24
HUP0100343A3 (en) 2001-09-28
US6262057B1 (en) 2001-07-17
GR3036702T3 (en) 2001-12-31
MA26569A1 (fr) 2004-12-20
KR20010032420A (ko) 2001-04-16
RU2182575C2 (ru) 2002-05-20
SK5942000A3 (en) 2000-10-09
WO1999028310A1 (en) 1999-06-10
MY119653A (en) 2005-06-30
NZ504461A (en) 2001-06-29
CA2310318C (en) 2003-10-21
DK1034171T3 (da) 2001-11-05
NO20002631D0 (no) 2000-05-23
EG23776A (en) 2007-08-08
PL340724A1 (en) 2001-02-26
ATE203237T1 (de) 2001-08-15
ID24964A (id) 2000-08-31
AU1327799A (en) 1999-06-16
PE134899A1 (es) 2000-01-11
NO314692B1 (no) 2003-05-05
NO20002631L (no) 2000-05-23
IL135544A0 (en) 2001-05-20
US6335331B2 (en) 2002-01-01
JP2007224042A (ja) 2007-09-06
CZ20001787A3 (cs) 2000-09-13
CN1279676A (zh) 2001-01-10
TR200001505T2 (tr) 2000-09-21
CN100406448C (zh) 2008-07-30
AR017676A1 (es) 2001-09-12
EP0919550A1 (en) 1999-06-02
SI20325A (sl) 2001-02-28
AU735819B2 (en) 2001-07-19
BG104424A (en) 2001-01-31
SK283237B6 (sk) 2003-04-01
CA2310318A1 (en) 1999-06-10
PL190871B1 (pl) 2006-02-28
BR9815405A (pt) 2000-10-10
EP1034171A1 (en) 2000-09-13
TWI225053B (en) 2004-12-11
TNSN98214A1 (fr) 2005-03-15
UA54568C2 (uk) 2003-03-17
ZA9810780B (en) 1999-05-31
US20010021712A1 (en) 2001-09-13
PT1034171E (pt) 2001-11-30
DE69801163T2 (de) 2002-03-28

Similar Documents

Publication Publication Date Title
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
HUP0003881A3 (en) Amidocarboxylic acid derivatives
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
HUP0001684A3 (en) Use of fumaric acid derivatives
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
HUP9901626A3 (en) Alkoxy acetic acid derivatives
HRP20000782B1 (en) New 3-aryl-2-hydroxypropionic acid derivative (i)
PL345794A1 (en) Aminomethylcarboxylic acid derivatives
PL340461A1 (en) Derivatives of isothiazocarboxylic acid
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
MXPA00012647A (es) Derivados n-sustituidos de acido 5-oxiiminobarbiturico.
GC0000094A (en) New pseudopolymorphic forms of 2-Ä2-Ä4-bis(4-fluorophenyl)methylÜ-1-piperazinylÜethoxyÜ acetic acid dihydrochloride.
AU7940598A (en) Quinolone carboxylic acid derivatives
EP0774965A4 (en) PHENOXYPHENYLACETIC ACID DERIVATIVES
PL331263A1 (en) Derivatives of glyoxylic acid
AU3791899A (en) (2-acylaminothiazole-4-yl)acetic acid derivatives
CY2392B1 (en) Method for the preparation of alpha-bromolactam derivatives.
PL335601A1 (en) Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid
ZA968179B (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives.
ZA965713B (en) 5-pyrazolylbenzoic acid derivatives.
AU5289299A (en) Divinylstilbenesulfonic acid derivatives
PL335373A1 (en) Method of obtaining derivatives of 4h-4-oxoquinolysine-3-carboxylic acid
PL339304A1 (en) Method of obtaining derivatives of 1-phenylparazolin-3-carboxylic acid
ZA989465B (en) Therapeutic uses of quinoline derivatives.
ZA973548B (en) Alkoxy acetic acid derivatives.